Table 2.
mRNA expression of fibulin-4 in human ovarian tissues
| N | Fibulin-4 mRNA | P | |
|---|---|---|---|
| Control | 40 | 0.0089 ± 0.0047 | |
| Benign | 60 | 0.0092 ± 0.0054 | >0.05 |
| Pathology type | >0.05 | ||
| Serous cystadenoma | 25 | 0.0091 ± 0.0058 | |
| Mucinous cystadenoma | 22 | 0.0098 ± 0.0067 | |
| Endometrioid tumor | 13 | 0.0084 ± 0.0035 | |
| Carcinoma | 16 | 0.0947 ± 0.0083 | <0.05 |
| Pathology type | 0 | >0.05 | |
| Serous cystadenocarcinoma | 58 | 0.0872 ± 0.0097 | |
| Mucinous cystadenocarcinoma | 56 | 0.0913 ± 0.0108 | |
| Endometrioid carcinoma | 46 | 0.0894 ± 0.0087 | |
| Cell differentiation | <0.05 | ||
| High and Medium | 88 | 0.0257 ± 0.0084 | |
| Low | 72 | 0.0968 ± 0.0113 | |
| Tumor stage | <0.05 | ||
| Low stage | 74 | 0.0284 ± 0.0075 | |
| High stage | 86 | 0.0895 ± 0.0118 | |
| Nodal status | <0.05 | ||
| Positive | 83 | 0.0983 ± 0.0094 | |
| Negative | 77 | 0.0309 ± 0.0081 |